HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaojie Wang Selected Research

Type 2 Diabetes Mellitus (MODY)

11/2021Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
1/2021Hypoglycemic Efficacy of Rh-aFGF Variants in Treatment of Diabetes in ZDF Rats.
10/2019Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
4/2019Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaojie Wang Research Topics

Disease

58Neoplasms (Cancer)
10/2022 - 01/2006
22Infections
04/2022 - 05/2008
16Neoplasm Metastasis (Metastasis)
01/2022 - 06/2010
15Wounds and Injuries (Trauma)
12/2022 - 08/2015
15Rectal Neoplasms (Rectal Cancer)
12/2021 - 09/2015
11Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2013 - 04/2002
10Inflammation (Inflammations)
03/2022 - 01/2014
10Insulin Resistance
01/2021 - 01/2014
9Stomach Neoplasms (Stomach Cancer)
03/2022 - 03/2004
9Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 08/2013
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2015
7Colonic Neoplasms (Colon Cancer)
11/2022 - 12/2017
7Obesity
01/2022 - 01/2014
7Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 02/2013
6Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2016
6Body Weight (Weight, Body)
01/2020 - 03/2016
5Fibrosis (Cirrhosis)
01/2022 - 01/2014
5Papillary Thyroid Cancer
01/2022 - 01/2018
5Carcinogenesis
09/2021 - 01/2014
5Disease Resistance
03/2020 - 07/2011
4Acute Kidney Injury (Acute Renal Failure)
12/2022 - 01/2018
4Kidney Diseases (Kidney Disease)
12/2022 - 04/2016
4Stroke (Strokes)
01/2022 - 01/2017
4Bacterial Infections (Bacterial Infection)
01/2022 - 12/2020
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2014
4Breast Neoplasms (Breast Cancer)
12/2021 - 01/2020
4Type 2 Diabetes Mellitus (MODY)
11/2021 - 04/2019
4Disease Progression
11/2020 - 05/2019
4Ischemia
09/2020 - 01/2010
4Hypoxia (Hypoxemia)
01/2020 - 01/2011
4Hyperglycemia
10/2019 - 03/2013
4Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 03/2016
4Carcinoma (Carcinomatosis)
01/2018 - 07/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 01/2015
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 12/2011
3Reperfusion Injury
12/2022 - 01/2017
3Proteinuria
12/2022 - 04/2011
3Brain Ischemia (Cerebral Ischemia)
07/2022 - 01/2017
3Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 05/2019
3Cognitive Dysfunction
05/2022 - 01/2016
3Cicatrix (Scar)
01/2022 - 01/2017
3Non-alcoholic Fatty Liver Disease
01/2022 - 03/2016
3Burns
01/2022 - 11/2019
3Diabetes Mellitus
01/2021 - 04/2011
3Hepatitis C
11/2020 - 11/2016
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2011
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
16fibroblast growth factor 21IBA
07/2022 - 12/2010
12Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2006
12Insulin (Novolin)FDA Link
11/2021 - 12/2010
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2013
10Pharmaceutical PreparationsIBA
03/2022 - 01/2011
9Biological ProductsIBA
07/2022 - 11/2006
6CytokinesIBA
01/2022 - 03/2005
6AntigensIBA
09/2021 - 04/2002
6HydrogelsIBA
02/2021 - 05/2018
6Cisplatin (Platino)FDA LinkGeneric
02/2021 - 03/2017
6LipidsIBA
12/2020 - 12/2010
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 02/2015
5CreatinineIBA
12/2022 - 04/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 06/2012
5AcidsIBA
10/2022 - 01/2015
5Particulate MatterIBA
04/2022 - 03/2019
4Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2014
4Peptides (Polypeptides)IBA
02/2021 - 03/2004
4Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020 - 01/2010
4Caspase 3 (Caspase-3)IBA
08/2017 - 09/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017 - 01/2006
4SurvivinIBA
02/2013 - 09/2006
3MicellesIBA
01/2022 - 01/2022
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2005
3CarbonIBA
01/2022 - 11/2018
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 08/2013
3CalciumIBA
01/2021 - 10/2011
3Blood Glucose (Blood Sugar)IBA
01/2021 - 12/2010
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2004
3Antiviral Agents (Antivirals)IBA
11/2020 - 11/2016
3Ethanol (Ethyl Alcohol)IBA
01/2020 - 01/2017
3MicroRNAs (MicroRNA)IBA
12/2019 - 02/2013
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2019 - 01/2010
3Triglycerides (Triacylglycerol)IBA
11/2019 - 12/2010
3Protein Isoforms (Isoforms)IBA
10/2019 - 01/2019
3Small Interfering RNA (siRNA)IBA
08/2019 - 09/2017
3Oxygen (Dioxygen)IBA
01/2018 - 03/2014
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 07/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2017 - 01/2017
3AlbuminsIBA
01/2017 - 04/2011
3Fluorouracil (Carac)FDA LinkGeneric
04/2016 - 02/2015
3Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2016 - 07/2011
3Transforming Growth Factors (Transforming Growth Factor)IBA
12/2014 - 08/2013

Therapy/Procedure

23Therapeutics
10/2022 - 08/2007
17Neoadjuvant Therapy
12/2021 - 04/2016
13Drug Therapy (Chemotherapy)
10/2022 - 12/2011
5Radiotherapy
11/2021 - 04/2016
4Colectomy
11/2022 - 02/2021
4Immunotherapy
01/2021 - 07/2015
4Transplantation
01/2020 - 02/2009
4Photochemotherapy (Photodynamic Therapy)
01/2018 - 01/2015
3Lymph Node Excision (Lymph Node Dissection)
06/2021 - 11/2018